10x Genomics Inc (NAS:TXG)
$ 24.29 -0.54 (-2.17%) Market Cap: 2.91 Bil Enterprise Value: 2.70 Bil PE Ratio: 0 PB Ratio: 4.04 GF Score: 75/100

10X Genomics Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 10, 2021 / 10:00PM GMT
Release Date Price: $164.77 (-4.60%)
Unidentified Analyst

Well, we have 10x here and happy to be hosting 10x on our second panel and go ahead and get started. Today, from 10x, we have Serge Saxonov, CEO; and Justin McAnear, the CFO. Welcome.

And just a reminder, if you would like to ask a question in the audience, we have instructions on the screen there, and there are also instructions on the tables.

Questions & Answers

Unidentified Analyst

So maybe just to get started here, maybe focusing a little on the 2Q results. You had pretty strong placements in the quarter following your pricing adjustment on the Chromium Controller. Can you talk a little bit about the strategy and the increase in instrument placements in the quarter?

Justin J. McAnear
10x Genomics, Inc. - CFO

Sure. So this is Justin McAnear, CFO. We lowered the price of the Chromium Controller to $35,000 in advance of the launch of Chromium X to make sure that we had the product positioned appropriately in our new lineup of instruments. And as we noted on our Q2 call, that drove about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot